Loading clinical trials...

Your health journey, clearly organized.

Legal

Phenotypic Properties in Individuals Affected With XLHED | Clinical Trials | Clareo Health

COMPLETED

Phenotypic Properties in Individuals Affected With XLHED

Phenotypic Properties in Individuals Affected With X-linked Hypohidrotic Ectodermal Dysplasia: Symptoms and Facial Recognition

NCT01871714•Edimer Pharmaceuticals

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

X Linked Hypohidrotic Ectodermal Dysplasia

Locations

United States

Locations (1)

Omni Houston Hotel

Houston, Texas, United States

Key Dates

Start Date

May 1, 2013

Primary Completion Date

July 1, 2013

Completion Date

September 1, 2013

Last Updated

November 27, 2013

Sponsors

Lead Sponsor

Edimer Pharmaceuticals

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 27, 2013Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions